Antagonizing the Endothelin B Receptor to Improve Aging-Dependent Neuronal Regenerative Decline

by | May 13, 2025 | Cavalli, Valeria, Feng, Rui

— Published Date: 12/21/24

Value proposition: A cost-effective, drug-based therapy targeting the endothelin B receptor (ETBR) to promote peripheral nerve regeneration, offering improved recovery and compatibility with existing treatments.

Technology Description

Researchers at Washington University…